Asston Pharmaceuticals IPO GMP Today
The Asston Pharmaceuticals IPO GMP is ₹26 (+21.1% over the upper price band of ₹123) as of 16 Jul 2025, giving an estimated listing price of ₹149 per share. On a minimum application of 2,000 shares, that is an estimated gain of ₹52,000. GMP has risen by ₹16 since tracking began on 4 Jul.
Last updated
- Issue Price
- ₹123
- GMP
- ₹26
- GMP %
- +21.1%
- Est. listing
- ₹149
- Est. gain / application
- +₹52,000
Asston Pharmaceuticals IPO GMP trend
Tracked for 13 days. High ₹30 on 10 Jul, low ₹10 on 4 Jul.
Asston Pharmaceuticals IPO GMP day-wise
| Date | GMP | Change | GMP % | Est. listing | Est. gain (2,000 sh) |
|---|---|---|---|---|---|
| (latest) | ₹26 | 0 | 21.14% | ₹149 | +₹52,000 |
| ₹26 | +₹1 | 21.14% | ₹149 | +₹52,000 | |
| ₹25 | -₹5 | 20.33% | ₹148 | +₹50,000 | |
| ₹30 | 0 | 24.39% | ₹153 | +₹60,000 | |
| ₹30 | 0 | 24.39% | ₹153 | +₹60,000 | |
| ₹30 | 0 | 24.39% | ₹153 | +₹60,000 | |
| ₹30 | +₹5 | 24.39% | ₹153 | +₹60,000 | |
| ₹25 | +₹10 | 20.33% | ₹148 | +₹50,000 | |
| ₹15 | +₹5 | 12.20% | ₹138 | +₹30,000 | |
| ₹10 | 0 | 8.13% | ₹133 | +₹20,000 | |
| ₹10 | 0 | 8.13% | ₹133 | +₹20,000 | |
| ₹10 | 0 | 8.13% | ₹133 | +₹20,000 | |
| ₹10 | — | 8.13% | ₹133 | +₹20,000 |
Est. listing = upper price band (₹123) + GMP. Est. gain = GMP × 2,000 shares (2 lots, the minimum application).
Asston Pharmaceuticals IPO subscription status
| QIB | 34.39x |
|---|---|
| Retail | 172.14x |
| Total | 130.96x |
Reading the Asston Pharmaceuticals IPO GMP
The grey market premium is the price above the issue price at which Asston Pharmaceuticals IPO shares are informally traded before listing. A GMP of ₹26 on an upper band of ₹123 suggests the shares could open around ₹149, if grey market sentiment holds until listing day.
GMP is not set by the company, the exchanges or SEBI. It moves daily with market conditions and subscription demand, and SME GMP in particular can swing sharply on low volumes. Check it together with the subscription numbers and the company's financials before applying.
Asston Pharmaceuticals IPO GMP: FAQs
- What is Asston Pharmaceuticals IPO GMP today?
- The latest grey market premium (GMP) for the Asston Pharmaceuticals IPO is ₹26 as of 16 July 2025, which is 21.14% over the upper price band of ₹123.
- What is the expected listing price of Asston Pharmaceuticals IPO?
- Based on the current GMP, the estimated listing price of Asston Pharmaceuticals IPO is ₹149 per share (₹123 issue price + ₹26 GMP). This is an estimate from unofficial grey market trades, not a guaranteed listing price.
- What is the lot size and minimum investment for Asston Pharmaceuticals IPO?
- The lot size is 1,000 shares. The minimum application is 2 lots (2,000 shares), which costs ₹2,46,000 at the upper price band.
- Is IPO GMP reliable?
- GMP reflects unofficial trades before listing and changes daily with market mood and subscription demand. It is a useful sentiment indicator but often differs from the actual listing price, so use it alongside the company's financials and subscription data.
GMP is an unofficial indicator compiled from grey market sources and is not investment advice. Actual listing prices can differ significantly. Read the offer document before investing.